🔎 Trials Near Me

Utama › Penyakit Kardiovaskular › Kansas › Kansas City

Kajian klinikal Penyakit Kardiovaskular di Kansas City, KS

14 kajian untuk Penyakit Kardiovaskular sedang mencari peserta di lokasi dalam dan sekitar Kansas City (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.

Teks kajian rasmi (Bahasa Inggeris)

Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →

ELEVATE-HFpEF Clinical Study

Mengambil peserta
  • University of Kansas Medical Center, Kansas City
Umur 40 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT06678841

Product Surveillance Registry

Mengambil pesertaKajian pemerhatian
  • Kansas City, Kansas City
Semua umur · Semua jantina · Dikemas kini 18 Sep 2026 · NCT01524276

Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease

Mengambil pesertaFasa 3
  • Clinical Trial Site, Kansas City
Umur 18 ke atas · Semua jantina · Dikemas kini 18 Sep 2026 · NCT07181109

Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation.

Mengambil peserta
  • University of Kansas Medical Center, Kansas City
Umur 18 ke atas · Semua jantina · Dikemas kini 15 Sep 2026 · NCT03242642

Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure

Mengambil peserta
  • The University Of Kansas Medical Center, Kansas City
Umur 18 hingga 100 · Semua jantina · Dikemas kini 9 Sep 2026 · NCT06310031

An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)

Mengambil pesertaFasa 3
  • University of Kansas Hospital, Kansas City
Umur 18 hingga 100 · Semua jantina · Dikemas kini 4 Sep 2026 · NCT07517263

A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD

Mengambil pesertaFasa 2
  • Clinical Research Site, Kansas City
Umur 18 hingga 85 · Semua jantina · Dikemas kini 2 Sep 2026 · NCT07333183

Pragmatic Evaluation of Events And Benefits of Lipid-lowering in Older Adults

Mengambil pesertaFasa 4Sukarelawan sihat dialu-alukan
  • University of Kansas Medical Center, Kansas City
Umur 75 ke atas · Semua jantina · Dikemas kini 1 Sep 2026 · NCT04262206

A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event

Mengambil pesertaFasa 3
  • Research Site, Kansas City
  • Research Site, Kansas City
Umur 18 ke atas · Semua jantina · Dikemas kini 24 Ogo 2026 · NCT07000357

OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events

Mengambil pesertaFasa 3
  • University of Kansas Medical Center, Kansas City
Umur 50 hingga 105 · Semua jantina · Dikemas kini 21 Ogo 2026 · NCT07136012

The Oxford Risk Factors And Non-Invasive Imaging Study

Mengambil pesertaKajian pemerhatian
  • Midwest Heart & Vascular Specialists LLC, Kansas City
  • St Luke's Hospital, Kansas City
Umur 18 hingga 99 · Semua jantina · Dikemas kini 31 Jul 2026 · NCT05169333

PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III

Mengambil peserta
  • University of Kansas Medical Center (KUMC), Kansas City
Umur 18 ke atas · Semua jantina · Dikemas kini 29 Jun 2026 · NCT05934487

Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure

Mengambil peserta
  • Kansas University Medical Center, Kansas City
Umur 18 ke atas · Semua jantina · Dikemas kini 10 Jun 2026 · NCT06526195

Sympathetic-vascular Dysfunction in Obesity and Insulin Resistance (Vitamin C Study)

Mengambil pesertaFasa 1/2
  • University of Kansas Medical Center, Kansas City
Umur 35 hingga 65 · Semua jantina · Dikemas kini 8 Jun 2025 · NCT04715022

Kajian Penyakit Kardiovaskular di bandar lain

Kajian lain di Kansas City

Daripada ClinicalTrials.gov, data diperoleh pada 6 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.